Amanta Healthcare IPO opened on September 1st and will be open for bidding until September 3rd. The company aims to raise Rs 126 crore, which will be used for a new manufacturing line and equipment purchase. The GMP is at a 22% premium before listing. Brokerage Anand Rathi has recommended subscribing to it for long-term investment.
Amanta Healthcare IPO: Amanta Healthcare launched its IPO on Monday, September 1, 2025, which will remain open until Wednesday, September 3. The company has set a price band of Rs 120-126 per share and aims to raise Rs 126 crore. The amount raised will be spent on a new manufacturing line and civil work for an SVP unit, equipment, and machinery in the Kheda district of Gujarat. The company had raised Rs 37.8 crore from anchor investors prior to the IPO. The grey market premium (GMP) is trading at a 22% premium, while brokerage firm Anand Rathi has recommended subscribing for long-term investment.
Price Band and Lot Size
Amanta Healthcare has set a price band of Rs 120 to Rs 126 per share for its IPO. Investors can bid for a minimum lot of 119 shares in this issue. At the upper price of Rs 126, a retail investor will have to invest at least Rs 14,994. This issue comprises only fresh equity shares and does not include an Offer For Sale (OFS) component.
Utilization of Funds Raised
A significant portion of the funds raised from the IPO will be utilized for the company's new manufacturing line and SVP unit in Hariyala, Kheda district, Gujarat. This will include civil construction, equipment, and the purchase of modern machinery. Additionally, the remaining amount will be used for general corporate purposes.
Anchor Investor Confidence Boost
The company had already raised Rs 37.8 crore through its anchor book before the IPO opened. On August 29th, the company allotted 30 lakh shares at Rs 126 per share to six institutional investors. These included Bandhan Mutual Fund, Sanshi Fund, Health to Wealth Rising Fund, Arth Growth Fund, Sunrise Investment Trust, and Finavenue Capital Trust. This anchor investment provided the company with initial confidence and led to market enthusiasm.
Company's Business Operations
Amanta Healthcare has been actively involved in the healthcare sector for a long time. The company focuses on enhancing its manufacturing capabilities and expanding its product portfolio. The company's strategy is to increase its customer base by working on complex drugs and new dosage forms. It also aims to strengthen relationships with existing customers.
Registrar and Book Running Lead Manager
MUFG Intime India has been appointed as the registrar for the Amanta Healthcare IPO. Beline Capital Advisors is the sole book running lead manager for this issue.
GMP Rally
According to market experts, the unofficial grey market premium (GMP) for Amanta Healthcare shares is steadily increasing. On Monday, its non-listed shares were trading at Rs 154, which is Rs 28 higher than the upper end of the company's price band of Rs 126. This translates to a premium of over 22 percent. This surge in GMP indicates b investor interest.
Investors Eyeing GMP and Subscriptions
IPO market experts state that the Amanta Healthcare issue is a topic of discussion among both retail and institutional investors. The support received from anchor investors in the initial phase, along with the robust GMP, is making this issue noteworthy. All eyes are now on the subscription numbers by September 3rd and the post-listing performance.
